USA - NASDAQ:RNLX - US75973T1016 - ADR
ChartMill assigns a Buy % Consensus number of 84% to RNLX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-07-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-05 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-03 | BTIG | Maintains | Buy |
| 2023-04-03 | HC Wainwright & Co. | Maintains | Buy |
| 2022-12-02 | HC Wainwright & Co. | Maintains | Buy |
| 2022-11-01 | HC Wainwright & Co. | Maintains | Buy |
| 2022-07-01 | BTIG | Maintains | Buy |
| 2022-07-01 | Stifel | Maintains | Buy |
| 2022-07-01 | HC Wainwright & Co. | Maintains | Buy |
| 2022-01-18 | HC Wainwright & Co. | Initiate | Buy |
| 2022-01-04 | BTIG | Initiate | Buy |
5 analysts have analysed RNLX and the average price target is 2.67 USD. This implies a price increase of 1187.44% is expected in the next year compared to the current price of 0.2071.
The consensus rating for RENALYTIX AI PLC-ADR (RNLX) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.